AI and Technology in Pharma
In conversation with experts
How human organs are rewriting the rules of drug development
How digital twins are pioneering a new era of personalized, longitudinal healthcare
Why Pharma can’t ignore friendshoring in supply chain
Inside Immunai’s plan to map the entire immune system
2025 in Review: Global biotech and funding trends
How ambient AI is capturing healthcare’s unheard data
Building resilient pharmaceutical supply chains in an era of disruption
Hospital of 2026: Local LLMs and AI Are Redefining Healthcare
Examining the growing delays in clinical trial start-up
Latest News
-
Dr. Jenna DiRito talks about why human organs may represent the “missing chapter” in our understanding of disease, and how this approach is already changing conversations with investors and regulators.
